http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
침윤성 자궁경부암 환자의 임상적 양상 및 예후에 관한 연구
김법종(Beob Jong Kim),이재규(Lee Jae Kyu),이주헌(Joo Heon Lee),유상영(Sang Young Ryu),김종훈(Jong Hoon Kim),김병기(Byoung Gie Kim),박상윤(Sang Yoon Park),이의돈(Eui Don Lee),이경희(Kyung Hee Lee) 대한산부인과학회 1999 Obstetrics & Gynecology Science Vol.42 No.9
Objectives: This non-randomized retrospective study was to investigate the clinical characteristics and to evaluate the actual 5-year survival rate of the patients with invasive cancer of the cervix. Methods: 489 evaluable patients with invasive cancer of the cervix were treated at Korea Cancer Center Hospital from January to December 1992. In this retrospective study, we studied the clinico-pathologic characteristics(age, FIGO stage, histologic type, nodal metastasis) and treatment modalities by the review of medical records. Especially, the survival was confirmed by the support of the police and government office. Results: The most common subsets of patients were found in the group of FIGO stage IIb(32.5%) and age between 51 and 60(33%). Surgery was the main treatment in stage Ib/IIa(65%) and radiation in stage IIb or more(97%). Nodal metastasis were surgically identified in 6% of stage Ib, 29% of stage IIa and 36% of stage IIb. Overall actual 5-year survival rate was 72.2%; stage Ia(100%), Ib(94%), IIa(82%), IIb(63%), IIIa(36%), IIIb(47%), and IV(0%). The five-year survival rate according to LN status in surgically confirmed FIGO stage Ib-II patients were 91.9% in negative patients and 73.1% in positive patients respectively. Five-year survival rate was significantly different according to stage(P < 0.02) and nodal metastasis(p < 0.01). However, age and histologic type did not show any significant differences in survival. Conclusion: Overall actual five-year survival rate of 489 evaluable patients with invasive cancer of the cervix who were treated at Korea Cancer Center Hospital from January to December 1992 was 72.2%. Five-year survival rate was different according to stage and nodal metastasis.
자궁경부암 환자에서 난소전위술 시행 후 발견된 난소 전이
김상헌 ( Sang Heon Kim ),권도영 ( Do Young Kwon ),유유숙 ( Yu Suk Yu ),김법종 ( Beob Jong Kim ),김문홍 ( Moon Hong Kim ),최석철 ( Seok Chul Choi ),유상영 ( Sang Young Ryu ) 대한산부인과학회 2009 Obstetrics & Gynecology Science Vol.52 No.9
In case of young women treated with ovarian preservation in cervical cancer surgery, it is regarded pertinent to reduce the risk of early menopause resulting from adjuvant pelvic irradiation through ovarian transposition. On the other hand, lots of authors have raised questions in regard with the ovary being possibly affected by micrometastasis. Studies have reported appropriate indications of ovarian transposition and risk factors of ovarian metastasis to cope with this problem. We conducted ovarian transposition with cervical cancer patient who had no ovarian metastasis risk factors reported in previous literature and experienced such case that metastasis took place only in the ovary without spreading to other organs. This study is to report that case based on brief literature review.
치료 후 임상적으로 무병상태인 자궁경부암 환자에서 FDG-PET scan의 임상적 유용성에 관한 연구
이재규(Lee Jae Kyu),김법종(Beob Jong Kim),황순혁(Soon Hyunk Hwang),유상영(Sang Young Ryu),김종훈(Jong Hoon Kim),김병기(Byoung Gie Kim),박상윤(Sang Yoon Park),이의돈(Eui Don Lee),이경희(Kyung Hee Lee),최창운(Chang Woon Choi),임상무(Sa 대한산부인과학회 1999 Obstetrics & Gynecology Science Vol.42 No.9
Objective: The purpose of this study was to investigate the clinical feasibility of FDG-PET (Positron Emission Tomography) scan in patients with clinically no evidence of disease after treatment of cervical cancer. Methods: One hundred and one patients with clinically NED(no evidence of disease) state after treatment of cervical cancer underwent PET scan. FDG-PET scan was obtained with a GE Advance Scanner, beginning at 50 minutes after injection of 370-555 MBq(10-15 mCi) of 18F FDG. Regional scan was also obtained with emission image. Uptake exceeding 3.0 SUV was determined as a positive finding. Recurrence was confirmed by CT, MRI, and needle biopsy if possible. Results: Among 101 patients showing no evidence of disease, 17 patients(16.8%) showed abnormal PET scan findings. Clinically, 8 patients(7.9%) were confirmed to have recurrent lesion by CT, MRI or by needle biopsy. PET scan could detect recurrent lesions in the mediastinum or lung(10/17), pelvis(7/17), and supraclavicular lymph node(2/17). The sensitivity and specificity of PET scan in patients with cervical cancer showing no evidence of disease were 100% and 90.3%, respectively. The positive predictive value, negative predictive value and false positive rate were 47.1%, 100% and 52.9%. Conclusion: PET scan could detect 7.9% of early recurrence in patients with cervical cancer with NED status. FDG-PET scan may be a useful method in detecting metastases or recurrence of a cervical cancer showing no evidence of disease by routine conventional imaging studies.
우희정 ( Hee Joung Woo ),김상헌 ( Sang Heon Kim ),김기동 ( Ki Dong Kim ),박상일 ( Sang Il Park ),송용중 ( Yong Jung Song ),김법종 ( Beob Jong Kim ),김문홍 ( Moon Hong Kim ),최석철 ( Seok Cheol Choi ),유상영 ( Sang Young Ryu ),이 대한산부인과학회 2009 Obstetrics & Gynecology Science Vol.52 No.2
Objective: The objective of this study was to examine the clinicopathologic characteristics and prognostic factors of primary peritoneal carcinoma (PPC). Methods: Clinicopathologic variables were obtained by examining the medical records of patients with PPC who were diagnosed and treated at our institute, between January 1996 and December 2005. To find prognostic factors, the association of clinicopathologic variables with survival was evaluated by univariate and multivariate analysis. Results: All patients had advanced-stage tumors. Residual tumor was smaller than 1 cm in 12 patients and was equal or larger than 1 cm in nine patients. The response rate to adjuvant chemotherapy was 47.6%. The median progression-free survival was eight months (range 1~95) and the median overall survival was 14 months (range 1~99). In univariate analysis, stage, the response to adjuvant chemotherapy, and neoadjuvant chemotherapy were associated with survival. However, in multivariate analysis, no variables were associated with survival. Conclusion: In spite of aggressive treatments, patients with PPC had poor prognosis. No prognostic factors were identified in this study.
이주헌(Joo Heon Lee),황순혁(Soon Hyunk Hwang),김법종(Beob Jong Kim),유상영(Sang Young Ryu),김종훈(Jong Hoon Kim),김병기(Byoung Gie Kim),박상윤(Sang Yoon Park),이의돈(Eui Don Lee),이경희(Kyung Hee Lee) 대한산부인과학회 1999 Obstetrics & Gynecology Science Vol.42 No.10
Objectives: To investigate clinicopathologic findings of patients with small cell carcinoma of uterine cervix, and to evaluate the recurrence pattern and prognosis of patients with small cell carcinoma of the uterine cervix. Methods: From Jan. 1990, to Dec. 1997, 23 patients with small cell carcinoma of the uterine cervix were registered and followed-up at Korea Cancer Center Hospital. Clinical characteristics, survival of these patients were studied retrospectively. Results: Among the 23 cases of small cell carcinoma of uterine cervix, 17 cases(74%) were of the neuroendocrine type (NE group), and 6 cases(26.0%) of the squamous cell type (SCC group). The median age, FIGO stage, and treatment modality were not significant difference between two groups. Pelvic lymph node metastases were found 53% in NE group, and 33% in SCC group, but there were not significant difference between two groups(p>0.05). Three patients showed distant metastases in NE group(bone 18%, bladder 9%), but there was no distant metastasis in SCC group. The 3 year survival rate was 50.0% in SCC group and 32.1% in NE group, but there were not statistical significance(p>0.05). Six patients showed recurrence after treatment (4/17 cases in NE group, 2/6 cases in SCC group). Recurrence sites were liver (3/6, 50%), and lung (2/6, 33%), brain (2/6, 33%), retroperitoneum (1/6, 17%), and axillae lymph node (1/6, 17%). Conclusion: This study showed neuroendocrine small cell carcinoma may have more aggressive than squamous small cell carcinoma, but there were not significant difference in prognosis between the two groups. Because of limitation of number of patients, further large scaled multicenter studies are needed.
자궁경부암 치료 후 FDG-PET로 무병상태 판정을 받은 환자의 무병기간 및 FDG-PET의 추적검사로서의 효용성에 대한 연구
박천숙 ( Chun Sook Park ),강정진 ( Jeong Jin Kang ),신혜림 ( Hae Rim Shin ),김명인 ( Myung In Kim ),김문홍 ( Moon Hong Kim ),천기정 ( Ki Jeong Chun ),김성은 ( Sung Eun Kim ),김법종 ( Beob Jong Kim ),최석철 ( Seok Chul Choi ),유상 대한산부인과학회 2004 Obstetrics & Gynecology Science Vol.47 No.12
Objective : This study was aimed to investigate the disease free interval and feasibility of FDG-PET for following up the patients with no evidence of cervical cancer after primary treatment. Methods : From May, 1998 to February, 2003, 406 patients with n
이삼미 ( Lee Sam Mi ),안준태 ( An Jun Tae ),박상일 ( Park Sang Il ),신혜림 ( Sin Hye Lim ),김법종 ( Kim Beob Jong ),김문홍 ( Kim Mun Hong ),최석철 ( Choe Seog Cheol ),이경희 ( Lee Gyeong Hui ),박선후 ( Park Seon Hu ) 대한산부인과학회 2003 Obstetrics & Gynecology Science Vol.46 No.12
Adenoid basal carcinoma of the uterine cervix is rare tumors that have often been regarded as a single entity. 14 cases with adenoid basal carcinoma of the uterine cervix have been reported in the literature. We experienced a case of 36-year female with a
안준태 ( An Jun Tae ),홍성진 ( Hong Seong Jin ),박상일 ( Park Sang Il ),송흥섭 ( Song Heung Seob ),김법종 ( Kim Beob Jong ),김문홍 ( Kim Mun Hong ),최석철 ( Choe Seog Cheol ),유상영 ( Yu Sang Yeong ),이경희 ( Lee Gyeong Hui ),이 대한산부인과학회 2004 Obstetrics & Gynecology Science Vol.47 No.1
In endometrial cancer, the risk of metastasis to bone seems to be rare. We describe the clinicopathologic features of a rare case of endometrial endometrioid adenocarcinoma presenting as a metastasis to the ischium in a 37-year-old premenopausal woman. Th